TIGAR and neoplasm: The complexity of these responses may reflect different contributions of ROS at different stages of the metastatic process or other alterations in the interaction between TIGAR null tumor cells and different components of the noncancer stromal compartments that may selectively mitigate against the toxic effect of elevated ROS.